Safe Supply Announces Sale Of NIRLAB Drug Analysis Device To Far North Resources Inc., Advancing Indigenous-Led Community Safety And Rapid Drug Identification

(MENAFN- Newsfile Corp) Safe Supply Announces Sale of NIRLAB Drug Analysis Device to Far North Resources Inc., Advancing Indigenous-Led Community Safety and Rapid Drug Identification

January 20, 2026 7:04 AM EST | Source: Safe Supply Streaming Co Ltd.

Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) (" Safe Supply " or the " Company "), a pioneer in health, safety and rapid response technologies, today announced the sale of a NIRLAB SA ("NIRLAB") NIRLIGHT spectroscopy drug analysis device to Far North Resources Inc., representing the first transaction completed under Safe Supply's exclusive Canadian distribution agreement with NIRLAB, and reinforcing its commitment to supporting Indigenous-led initiatives focused on community health, safety, and evidence-based decision-making.

The transaction marks an important step in expanding access to advanced, non-destructive drug identification technology within Indigenous communities, while also highlighting the broader public-safety applications of rapid, high-confidence substance analysis.

"This transaction reflects our belief that effective health and safety begins with access to credible, real-time information," said Shane Diakunchak, Chief Executive Officer of Far North Resources Inc. "By integrating advanced analytical tools like the NIRLAB device into Indigenous-led initiatives, communities can respond faster, act with greater confidence, and maintain control over how safety solutions are implemented locally."

Supporting Indigenous Communities Through Technology-Enabled Health & Safety

Indigenous communities across Canada continue to face disproportionate risks related to the unpredictable and increasingly complex illicit drug supply. The deployment of the NIRLAB device through Far North Resources Inc. reflects a community-first approach, placing advanced analytical tools directly in the hands of organizations that are trusted, locally embedded, and best positioned to respond quickly to emerging risks.

The NIRLAB system enables rapid, non-contact analysis of drug samples, providing immediate insight into substance composition and relative purity without destroying the sample. This capability supports a wide range of community-level objectives, including:

• Early risk identification when new or unusually potent substances emerge

• Timely, informed decision-making for community safety initiatives

• Improved situational awareness for frontline and support organizations

• Education and prevention efforts grounded in real-time data rather than delayed laboratory results

By enabling faster understanding of what substances are present, and in what relative concentrations, the technology helps reduce uncertainty in environments where uncertainty can carry serious consequences.

"Safe Supply's mission has always been to support practical, scalable technologies that improve real-world safety outcomes," said Geoff Benic, Chief Executive Officer of Safe Supply. "This sale underscores both the analytical credibility of the NIRLAB platform and the importance of working alongside Indigenous partners who are leading meaningful, community-driven responses."

Demonstrated Speed, Accuracy, and Analytical Reliability

The NIRLAB device has demonstrated a high degree of analytical reliability in operational settings. In validation use cases, samples previously characterized through conventional laboratory workflows were independently analyzed using the NIRLAB system.

The device successfully identified the same chemical composition and relative percentage profile reflected in the corresponding certificate of analysis as a regular process, delivering results in approximately six seconds.

Unlike traditional analytical processes, which can require days or weeks to return results, the NIRLAB system is capable of providing near-instant insight while maintaining analytical consistency. This combination of speed and accuracy is particularly relevant in time-sensitive contexts, where delayed information can materially affect outcomes.

Relevance to Public Safety and Investigative Environments

Beyond community-based health and safety, the rapid, non-destructive nature of near-infrared spectroscopy offers meaningful advantages in broader public-safety and investigative applications. Immediate analysis allows for:

• Rapid screening and triage of unknown substances

• Preservation of samples for follow-up or evidentiary use

• Reduced handling and exposure risk

• Greater operational efficiency when time and clarity are critical

"Speed and accuracy are not abstract concepts in safety-critical environments, they are decisive factors," said Raf Souccar, Chairman of the Board of Safe Supply. "Technologies that deliver reliable analytical insight in seconds, rather than weeks, can materially enhance decision-making and operational effectiveness across a wide range of public-safety contexts."

Building a Responsible, Scalable Technology Ecosystem

The sale further strengthens Safe Supply's collaboration with NIRLAB and Far North Resources Inc. as part of a broader effort to responsibly expand access to validated, field-deployable drug identification technologies. The Company believes that deploying such tools through trusted, community-based partners is essential to improving safety outcomes for Indigenous communities and the general population alike.

Abour Far North Resources Inc.

Far North Resources Inc. is an advisory firm focused on advancing sustainable development and socio-economic opportunity in First Nation and Northern communities. As part of the Far North Development Group, the firm brings over 30 years of experience working with Indigenous communities, governments, and private sector partners, providing strategic advisory services in areas including resource development, infrastructure and essential services, joint venture structuring, and community-focused negotiation, with all initiatives grounded in trust, cultural understanding, and long-term shared value.

About NIRLAB SA

NIRLAB SA is a Swiss spin-off from the Forensic Institute of the University of Lausanne that develops handheld near-infrared (NIR) spectroscopy solutions for on-site identification and quantification of substances. Its NIRLIGHT analyzer, paired with a cloud-based mobile and web app, brings high precision labs to the field and enables rapid decision making based on trustable data in drug checking and law-enforcement contexts internationally.

About Safe Supply Streaming Co Ltd.

Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) is a publicly traded company building and backing innovations in healthcare, wellness, and emerging technologies. Through acquisitions, partnerships, and growth capital, the Company assembles a diversified portfolio that leverages data, science, and digital platforms to improve access and outcomes at scale. Operating at the intersection of public health and technology, Safe Supply supports evidence-informed solutions to urgent societal needs. Its wholly owned subsidiaries, including Safety Strips Tech Corp. and Drug Lab 118 Ltd., develop proprietary rapid-testing technologies-such as single-use presumptive fentanyl and drink-spiking detection products.

For more information, please visit .

On behalf of the Board of Directors of Safe Supply Streaming Co Ltd.,

"Geoff Benic"
Geoff Benic, CEO

Media & Investor Contact:

Safe Supply Streaming Co Ltd.
Email: ...
Geoff Benic, Chief Executive Officer
Email: ...

Phone: +1 647-880-7314
Website:

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this news release and has neither approved nor disapproved its contents.

Cautionary Note Regarding Forward-Looking Statements

This press release contains certain statements that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian securities laws. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated benefits, effectiveness, adoption, and potential applications of the NIRLAB technology; the expected impact of the Company's partnerships with Far North Resources Inc. and NIRLAB SA; and the role of advanced analytical technologies in improving community health, safety, and public-safety outcomes.

Forward-looking statements are based on management's current expectations, assumptions, and beliefs as of the date hereof and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or developments to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, changes in regulatory environments, operational or technological limitations, market acceptance, reliance on third-party partners, and other risks detailed from time to time in the Company's public disclosure filings.

Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise.

To view the source version of this press release, please visit

Source: Safe Supply Streaming Co Ltd.

MENAFN20012026004218003983ID1110623863